ÂÜÀòÂÒÂ×

Hale McKirnan currently serves as the National Director of Payer Accounts at Merz Therapeutics, a role commenced in April 2021, focusing on payer strategy for XEOMIN, Inbrija, and Ampyra while leading the National Account team. Prior experience includes holding the position of National Account Director at Merz, where recognition as a President's Club Recipient was achieved for both FY '21-'22 and FY '22-'23. Hale also served as a Senior Regional Account Manager at AbbVie from May 2020 to April 2021 and was a 2019 Champions Circle Recipient. Earlier career experience at Allergan, which included roles such as Associate Director of Regional Accounts and various managerial positions, spanned from September 2007 to May 2020. Hale McKirnan earned a degree from The University of Memphis between 1999 and 2003.